Argatroban anticoagulation in obese versus nonobese patients: Implications for treating heparin-induced thrombocytopenia

被引：18
|
作者：
Rice, Lawrence
Hursting, Marcie J.
Baillie, G. Mark
McCollum, David A.
机构：
[1] Methodist Hosp, Weill Cornell Med Coll, Houston, TX 77030 USA
[2] Clin Sci Consulting, Austin, TX USA
[3] CTI Clin Trial & Consulting Serv, Cincinnati, OH USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 47卷 / 08期
关键词：
heparin-induced thrombocytopenia; obesity; argatroban; body mass index; thrombosis;
D O I：
10.1177/0091270007302951
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1028 / 1034
页数：7
相关论文
共 50 条
  • [21] Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban
    Warkentin, TE
    THROMBOSIS RESEARCH, 2003, 110 (2-3) : 73 - 82
  • [22] Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia
    Marchetti, Matteo
    Barelli, Stefano
    Gleich, Tobias
    Gomez, Francisco J.
    Goodyer, Matthew
    Grandoni, Francesco
    Alberio, Lorenzo
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (06) : 766 - 790
  • [23] Efficacy and Safety of Argatroban and Bivalirudine in Patients with Suspected Heparin-Induced Thrombocytopenia
    Vo, Quynh-Anh T.
    Lin, Joyce K.
    Tong, Lisa M.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (02) : 178 - 184
  • [24] Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia
    Hursting, MJ
    Lewis, BE
    Macfarlane, DE
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (03) : 279 - 287
  • [25] Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia
    Al-Eidan, Fahad A. S.
    Alrawkan, Saud
    Alshammary, Huda
    Crowther, Mark A.
    ANNALS OF HEMATOLOGY, 2018, 97 (11) : 2055 - 2059
  • [26] Argatroban therapy in patients with coronary artery disease and heparin-induced thrombocytopenia
    Jang, Ik-Kyung
    Hursting, Marcie J.
    McCollum, David
    CARDIOLOGY, 2008, 109 (03) : 172 - 176
  • [27] Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia
    Fahad A. S. Al-Eidan
    Saud Alrawkan
    Huda Alshammary
    Mark A. Crowther
    Annals of Hematology, 2018, 97 : 2055 - 2059
  • [28] Safety and Efficacy of Argatroban in the Management of Heparin-Induced Thrombocytopenia
    Saugel, Bernd
    Schmid, Roland M.
    Huber, Wolfgang
    CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS, 2011, 4 : 11 - 19
  • [29] Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia
    Kondo, LM
    Wittkowsky, AK
    Wiggins, BS
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (04) : 440 - 451
  • [30] Comparison of Bivalirudin and Argatroban for the Management of Heparin-Induced Thrombocytopenia
    Skrupky, Lee P.
    Smith, Jennifer R.
    Deal, Eli N.
    Arnold, Heather
    Hollands, James M.
    Martinez, Emily J.
    Micek, Scott T.
    PHARMACOTHERAPY, 2010, 30 (12): : 1229 - 1238
12345